Challenges and Opportunities When Developing Devices for Rare Disease Populations

Expert Opinion on Orphan Drugs - United Kingdom
doi 10.1517/21678707.2016.1166948
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare


Related search